Skip to main navigation
Skip to search
Skip to main content
Ewha Womans University Home
Search content at Ewha Womans University
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Press/Media
Updated treatment guideline of chronic spontaneous urticaria
Joo Young Roh
Department of Dermatology
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Updated treatment guideline of chronic spontaneous urticaria'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Omalizumab
100%
H1 Antagonist
40%
Decision-Making
20%
Antihistamines
20%
Immunoglobulin G
20%
Immunoglobulin E
20%
Immunoglobulin E Receptor
20%
Immunoglobulin E Antibody
20%
Immunoglobulin Antibody
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Urticaria
100%
Omalizumab
45%
Add on Therapy
18%
Histamine H1 Receptor Antagonist
18%
Controlled Clinical Trial
9%
Prevalence
9%
Skin Disease
9%
Antihistaminic Agent
9%
Immunoglobulin Antibody
9%
Immunoglobulin E
9%
Monotherapy
9%
Immunoglobulin E Antibody
9%
Immunoglobulin G
9%
Immunoglobulin E Receptor
9%
Medicine and Dentistry
Chronic Urticaria
100%
Omalizumab
45%
H1 Antagonist
18%
Add on Therapy
18%
Prevalence
9%
Controlled Clinical Trial
9%
Monotherapy
9%
Histamine Antagonist
9%
Immunoglobulin G
9%
Immunoglobulin E
9%
Immunoglobulin E Receptor
9%
Immunoglobulin Antibody
9%
Immunoglobulin E Antibody
9%